News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
36 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27691)
Month
January (2434)
February (2869)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (2567)
Day
1 (167)
2 (22)
3 (10)
4 (48)
5 (185)
6 (145)
7 (156)
8 (155)
9 (41)
12 (152)
13 (137)
14 (135)
15 (192)
16 (43)
18 (37)
19 (173)
20 (163)
21 (127)
22 (143)
23 (101)
25 (36)
26 (199)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
Day
1
2
3
4
5
6
7
8
9
12
13
14
15
16
18
19
20
21
22
23
25
26
Press Releases
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
October 25, 2026
·
9 min read
Press Releases
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
October 25, 2026
·
17 min read
Press Releases
Salus Scientific Highlights Comprehensive Approach to Procedural Workforce Protection at TCT 2026
October 25, 2026
·
4 min read
Press Releases
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
October 25, 2026
·
9 min read
Press Releases
Tampa General Hospital and Health Care District of Palm Beach County to Open Lakeside Cancer Center in September 2027, Expanding Access to Academic-Based Cancer Care in Florida’s Rural Communities
October 25, 2026
·
7 min read
Press Releases
Novo’s Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older with type 2 diabetes
October 25, 2026
·
13 min read
Previous
4 of 4